Skip to main content
Caplight Logo









DeNovaMed Inc.

DeNovaMed Inc.

Private
HalifaxHealthcare & Life Scienceshttps://denovamed.com/

Last Round

Seed

Aug 8, 2012

Total Funding Raised

$1.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

DeNovaMed Inc. is a biotechnology company that develops novel antibiotic therapies to combat drug-resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibiotic discoverydrug-resistant bacteriasuperbugscomputer-aided drug designCADDsmall-molecule antibioticsdiabetic foot ulcerspreclinical developmentinvestigational new drugINDmicropharmabiotech startupbacterial lipid metabolismACP synthase

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeNovaMed Inc. Comparables

Compare DeNovaMed Inc. with similar companies based on industry and business-model similarity.

DeNovaMed Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sequella, Inc.
80%
Deinove
78%
Microbion Corporation
77%

DeNovaMed Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 8, 2012
GrantApr 1, 2012

Key People

Founding team and executive leadership

Christopher McMaster

President and CEO

Executive Team

DeNovaMed Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 30% MoM.

  • Jul 27, 2026

    Monthly visitors grew 126% MoM.

DeNovaMed Inc. Filings

Explore SEC and related filing metadata, where available.

DeNovaMed Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DeNovaMed Inc.'s valuation, stock price, and market status.

Is DeNovaMed Inc. a public or private company?

DeNovaMed Inc. is a private company.

What is the current stock price of DeNovaMed Inc.?

DeNovaMed Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is DeNovaMed Inc. worth (valuation)?

Valuation information for DeNovaMed Inc. is not publicly available.

Can I buy DeNovaMed Inc. stock?

DeNovaMed Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DeNovaMed Inc.'s last funding round?

DeNovaMed Inc.'s most recent funding round was Seed on August 8, 2012.

Who are the main investors in DeNovaMed Inc.?

Key investors in DeNovaMed Inc. include Innovacorp.

Will DeNovaMed Inc. IPO soon?

No public IPO plans have been announced for DeNovaMed Inc..

How can I track DeNovaMed Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeNovaMed Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHalifax
Employee Range5
Year Founded2006
Last FundingAug 8, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?